Gilead Systems wins the Triple Crown
Thursday, April 10th, 2008
Gilead Systems wins the Triple Crown – simultaneously improving revenues, reducing costs and enhancing service.
As Business Week puts it in the prelude to this years review of the top 50 performers in Standard and Poors 500 stock index “for many years pharmaceutical companies viewed the development of HIV treatments as a necessary – but unprofitable – public service. There was some logic to that view, given that the majority of victims lived in developing nations and were unable to pay what drug makers could earn from selling other products. But Gilead Systems had a different perspective"